NEXTCURE, INC Debt Instrument, Interest Rate During Period
NEXTCURE, INC (NXTC) reported Debt Instrument, Interest Rate During Period of 4.25% for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-04.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentInterestRateDuringPeriod · last filed 2021-03-04
- NEXTCURE, INC debt instrument, interest rate during period for the quarter ending 2019-09-30 was 4.33%, a 3.59% increase year-over-year.
- NEXTCURE, INC debt instrument, interest rate during period for the quarter ending 2019-06-30 was 4.50%, a 18.73% increase year-over-year.
- NEXTCURE, INC debt instrument, interest rate during period for the quarter ending 2019-03-31 was 4.50%, a 20.00% increase year-over-year.
- NEXTCURE, INC debt instrument, interest rate during period for the quarter ending 2018-09-30 was 4.18%.
- NEXTCURE, INC debt instrument, interest rate during period for fiscal 2020 was 4.25%, a 3.41% decline from fiscal 2019.
- NEXTCURE, INC debt instrument, interest rate during period for fiscal 2019 was 4.40%, a 11.39% increase from fiscal 2018.
- NEXTCURE, INC debt instrument, interest rate during period for fiscal 2018 was 3.95%.
| Period end | Debt Instrument, Interest Rate During Period | Debt Instrument, Interest Rate During Period 3 month | Debt Instrument, Interest Rate During Period 6 month | Debt Instrument, Interest Rate During Period 9 month | Debt Instrument, Interest Rate During Period 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | 4.25% 10-K · filed 2021-03-04 | ||||
| 2019-12-31 | 4.40% 10-K · filed 2021-03-04 | ||||
| 2019-09-30 | 4.33% 10-Q · filed 2019-11-12 | 4.44% 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | 4.50% 10-Q · filed 2019-08-12 | 4.50% 10-Q · filed 2019-08-12 | |||
| 2019-03-31 | 4.50% 10-Q · filed 2019-06-10 | ||||
| 2019-01-25 | 4.25% 10-K · filed 2021-03-04 | ||||
| 2018-12-31 | 3.95% 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | 4.18% 10-Q · filed 2019-11-12 | 3.84% 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | 3.79% 10-Q · filed 2019-08-12 | 3.66% 10-Q · filed 2019-08-12 | |||
| 2018-03-31 | 3.75% 10-Q · filed 2019-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |